Focusing on a targeted group of patients and trials has led to more small batch productions throughout the industry. These products are often expensive and very limited within the pharmaceutical industries. When having a limited amount of product for manufacturing, issues and rejects must be near zero.
Although, product loss is unavoidable—most product loss is during the filtration process. In small batch productions, it is extremely important to minimize as much loss of a product as possible during all phases of product manufacturing. Keeping track of yield, accuracy and implementation is necessary to reach maximum use of each product being created. Containers have to be filled perfectly to reach the zero-defect goal.
The requirements and need for new dosage formats used during different trials are in constant rotation; therefore, flexibility of the machinery being used is important for small batch production. During testing of the new products, data implementation and documentation is extremely important in order to determine correct dosages for each product. Drug development typically starts in an academic or R&D lab setting; then moves to manufacturers once testing shows positive results.
The Identifier software, focuses on each product by limiting rejects, keeping track of yield/ accuracy and blinds for data integrity purposes. Data implementation to the software will easily help determine if a product passes or fails visual inspection.
Does your small batch production have security of the data being imported is true and accurate?
Read the full article published by Pharmaceutical Online.
